Filed: 5/15/2026ACC: 0000935836-26-000270
📋 What this filing means
ECOR1 CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $2.36B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$2.36B
Total AUM (reported)
91.63M
Total Shares
Allocation by class
COM$1.53B64.8%
SHS USD$322.61M13.7%
SPONSORED ADS$254.64M10.8%
COM ADDED$94.06M4.0%
NAMEN AKT$66.09M2.8%
SPON ADR$50.01M2.1%
COM NEW$28.75M1.2%
Portfolio Concentration
Top 3$1.33B56.6%
4–10$776.21M32.9%
11–25$239.65M10.2%
Rest$5.64M0.2%
Top 3 weight
56.6%
Top 10 weight
89.6%
Voting Authority Distribution
Total shares with voting rights: 91.63M
Sole
Full voting authority
91.63M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
ZYMEWORKS INC
SOLEShares22.97M
TypeSH
Market value$575.18M
24.41%
Sole
22.97M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares7.88M
TypeSH
Market value$437.03M
18.55%
Sole
7.88M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares1.71M
TypeSH
Market value$322.61M
13.69%
Sole
1.71M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares6.41M
TypeSH
Market value$254.64M
10.81%
Sole
6.41M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares4.29M
TypeSH
Market value$155.74M
6.61%
Sole
4.29M
Shared
0.00
None
0.00
AKTIS ONCOLOGY INC
SOLEShares4.82M
TypeSH
Market value$86.31M
3.66%
Sole
4.82M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$85.25M
3.62%
Sole
6.73M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares1.10M
TypeSH
Market value$74.58M
3.17%
Sole
1.10M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares1.39M
TypeSH
Market value$66.09M
2.80%
Sole
1.39M
Shared
0.00
None
0.00
ETON PHARMACEUTICALS INC
SOLEShares2.17M
TypeSH
Market value$53.60M
2.27%
Sole
2.17M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares1.67M
TypeSH
Market value$50.01M
2.12%
Sole
1.67M
Shared
0.00
None
0.00
XENCOR INC
SOLEShares2.18M
TypeSH
Market value$26.33M
1.12%
Sole
2.18M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.27M
TypeSH
Market value$25.63M
1.09%
Sole
1.27M
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.82M
TypeSH
Market value$25.27M
1.07%
Sole
2.82M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares777K
TypeSH
Market value$23.19M
0.98%
Sole
777K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares1.90M
TypeSH
Market value$18.95M
0.80%
Sole
1.90M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares789.50K
TypeSH
Market value$15.43M
0.66%
Sole
789.50K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares900K
TypeSH
Market value$14.56M
0.62%
Sole
900K
Shared
0.00
None
0.00
EIKON THERAPEUTICS INC
SOLEShares732.61K
TypeSH
Market value$7.75M
0.33%
Sole
732.61K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares1M
TypeSH
Market value$7.65M
0.32%
Sole
1M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares1.18M
TypeSH
Market value$7.02M
0.30%
Sole
1.18M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares625K
TypeSH
Market value$6.94M
0.29%
Sole
625K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares13.37M
TypeSH
Market value$4.41M
0.19%
Sole
13.37M
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$3.26M
0.14%
Sole
100K
Shared
0.00
None
0.00
PRELUDE THERAPEUTICS INC
SOLEShares947.05K
TypeSH
Market value$3.24M
0.14%
Sole
947.05K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZYMEWORKS INCSOLE | COM | 22.97M | SH | $575.18M 24.41% | 22.97M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 7.88M | SH | $437.03M 18.55% | 7.88M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 1.71M | SH | $322.61M 13.69% | 1.71M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 6.41M | SH | $254.64M 10.81% | 6.41M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 4.29M | SH | $155.74M 6.61% | 4.29M | 0.00 | 0.00 |
AKTIS ONCOLOGY INCSOLE | COM ADDED | 4.82M | SH | $86.31M 3.66% | 4.82M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $85.25M 3.62% | 6.73M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 1.10M | SH | $74.58M 3.17% | 1.10M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 1.39M | SH | $66.09M 2.80% | 1.39M | 0.00 | 0.00 |
ETON PHARMACEUTICALS INCSOLE | COM | 2.17M | SH | $53.60M 2.27% | 2.17M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 1.67M | SH | $50.01M 2.12% | 1.67M | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 2.18M | SH | $26.33M 1.12% | 2.18M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.27M | SH | $25.63M 1.09% | 1.27M | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 2.82M | SH | $25.27M 1.07% | 2.82M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 777K | SH | $23.19M 0.98% | 777K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 1.90M | SH | $18.95M 0.80% | 1.90M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 789.50K | SH | $15.43M 0.66% | 789.50K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 900K | SH | $14.56M 0.62% | 900K | 0.00 | 0.00 |
EIKON THERAPEUTICS INCSOLE | COM ADDED | 732.61K | SH | $7.75M 0.33% | 732.61K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 1M | SH | $7.65M 0.32% | 1M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 1.18M | SH | $7.02M 0.30% | 1.18M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 625K | SH | $6.94M 0.29% | 625K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 13.37M | SH | $4.41M 0.19% | 13.37M | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 100K | SH | $3.26M 0.14% | 100K | 0.00 | 0.00 |
PRELUDE THERAPEUTICS INCSOLE | COM | 947.05K | SH | $3.24M 0.14% | 947.05K | 0.00 | 0.00 |
Page 1 of 2